Jiangsu Aidea Pharmaceutical Group Co., Ltd. (SHA:688488)

SHA:688488 Revenue

Jiangsu Aidea Pharmaceutical Group had revenue of 189.92M CNY in the quarter ending September 30, 2025, with 61.21% growth. This brings the company's revenue in the last twelve months to 671.33M, up 64.27% year-over-year. In the year 2024, Jiangsu Aidea Pharmaceutical Group had annual revenue of 417.80M with 1.57% growth.

• Revenue (ttm): 671.33M
• Revenue Growth: +64.27%
• P/S Ratio: 11.39
• Revenue / Employee: 953.59K
• Employees: 704
• Market Cap: 7.65B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	417.80M	6.44M	1.57%
Dec 31, 2023	411.36M	167.14M	68.44%
Dec 31, 2022	244.22M	-11.49M	-4.49%
Dec 31, 2021	255.71M	-33.35M	-11.54%
Dec 31, 2020	289.06M	-56.17M	-16.27%